Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menactra antibody response in healthy adults
NCT00772629Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Jan 2004
- Primary completion
- Apr 2004
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of meningococcal A conjugate vaccine in meningococcal meningitis, meningococcemia, sponsored by Sanofi. Started Jan 2004; status: terminated.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
meningococcal meningitismeningococcemia
Beyond the preview
Go deeper on NCT00772629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00772629.